Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
Employee Happiness in the Age of AI
In this report, AlixPartners and Darwin X argue that retail consistently trails other industries on employee happiness, and that closing that gap is not just a people issue, but a prerequisite for competing in the ag...
The Future of Executive Leadership and High Performance
Andrew Darfoor, SID, Post Office & Board Mentor at Criticaleye, and Jodene Young, Chief People Officer at the National Physical Laboratory (NPL), join Bridgette Hall, Senior Editor at Criticaleye, for a discussio...
VIEWPOINTS | How to Create Forward-thinking Boards
Good governance and effective oversight are the baseline for high-performing Boards. What distinguishes the absolute best is the way in which executive and non-executive directors support and challenge each other on ...
Displaying 1 to 3 of 197
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
